Renaissance Technologies’s Agile Therapeutics AGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-59,200
Closed -$115K 4237
2023
Q4
$115K Buy
+59,200
New +$119K ﹤0.01% 3272
2023
Q1
Sell
-476
Closed -$5K 4525
2022
Q4
$5K Sell
476
-2,558
-84% -$29.7K ﹤0.01% 4066
2022
Q3
$45K Buy
3,034
+585
+24% +$14.4K ﹤0.01% 3785
2022
Q2
$143K Buy
2,449
+2,138
+687% +$310K ﹤0.01% 3755
2022
Q1
$130K Buy
311
+230
+284% +$147K ﹤0.01% 3750
2021
Q4
$80K Buy
81
+63
+350% +$88.9K ﹤0.01% 3722
2021
Q3
$35K Sell
18
-400
-96% -$905K ﹤0.01% 3394
2021
Q2
$1.11M Buy
418
+226
+118% +$745K ﹤0.01% 2624
2021
Q1
$798K Buy
+192
New +$1.04M ﹤0.01% 2709
2020
Q3
Sell
-72
Closed -$401K 3792
2020
Q2
$401K Sell
72
-424
-85% -$2.2M ﹤0.01% 2938
2020
Q1
$1.85M Sell
496
-1,137
-70% -$6.53M ﹤0.01% 2091
2019
Q4
$8.16M Buy
1,633
+419
+35% +$1.46M 0.01% 1571
2019
Q3
$2.88M Buy
1,214
+87
+8% +$214K ﹤0.01% 2078
2019
Q2
$3.29M Buy
1,127
+60
+6% +$168K ﹤0.01% 2073
2019
Q1
$3.22M Buy
1,067
+97
+10% +$206K ﹤0.01% 2074
2018
Q4
$1.12M Buy
970
+358
+58% +$549K ﹤0.01% 2517
2018
Q3
$449K Buy
612
+216
+55% +$158K ﹤0.01% 2880
2018
Q2
$392K Buy
396
+171
+76% +$600K ﹤0.01% 2902
2018
Q1
$1.16M Buy
225
+42
+23% +$278K ﹤0.01% 2597
2017
Q4
$985K Buy
183
+139
+316% +$1.29M ﹤0.01% 2661
2017
Q3
$395K Buy
+44
New +$338K ﹤0.01% 2845
2017
Q2
Sell
-17
Closed -$109K 3418
2017
Q1
$109K Sell
17
-15
-47% -$75.4K ﹤0.01% 3073
2016
Q4
$365K Buy
32
+22
+220% +$308K ﹤0.01% 2859
2016
Q3
$144K Buy
+10
New +$143K ﹤0.01% 3129
2015
Q3
Sell
-23
Closed -$390K 3424
2015
Q2
$390K Buy
23
+3
+15% +$64K ﹤0.01% 2791
2015
Q1
$368K Buy
+20
New +$351K ﹤0.01% 2699

Other funds holding AGRX